Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Due to Spinal Cord Injury
Status:
Terminated
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
A drug called AV650 (tolperisone HCl) will be given to patients who have spasticity following
a spinal cord injury. This study has three purposes:
1. To determine whether AV650 is safe for patients with spinal cord injury;
2. To assess what the body does with AV650 once it is ingested; and,
3. To gather some early evidence as to whether AV650 is effective in treating spasticity in
patients with spinal cord injury.